Education & Training
Selected Honors & Awards
- DAiuto L, Williamson K, Dimitrion P, McNulty J, Brown CE, Dokuburra CB, Nielsen AJ, Lin WJ, Piazza P, Schurdak ME, Wood J, Yolken RH, Kinchington PR, Bloom DC, Nimgaonkar VL (2017). Comparison of three cell-based drug screening platforms for HSV-1 infection. Antiviral Research. 142, 136-140.
- Ganapathiraju MK, Thahir M, Handen A, Sarkar SN, Sweet RA, Nimgaonkar VL, Loscher CE, Bauer EM, Chaparala S: Schizophrenia interactome with 504 novel proteinprotein interactions (2016). Schizophrenia, 2:16012
- Das DK, Tapias V, DAiuto L, Chowdari KV, Francis L, Zhi Y, Ghosh A, Surti U, Tischfield J, Sheldon M, Moore JC, Fish K, Nimgaonkar VL (2015). Genetic and morphological features of human iPSC-derived neurons with chromosome 15q11.2 (BP1-BP2) deletions. Molecular Neuropsychiatry. 1:116-123 (DOI:10.1159/000430916). PMID: 26528485.
- Prasad KM, Eack SM, Keshavan MS, Yolken RH, Iyengar S, Nimgaonkar VL. (2013) Antiherpes VirusSpecific Treatment and Cognition in Schizophrenia: A Test-of-Concept Randomized Double-Blind Placebo-Controlled Trial. Schizophrenia Bulletin. 39(4):857-66. doi: 10.1093/schbul/sbs040. Epub 2012 Mar 23. PMID: 22446565, PMCID: PMC3686443.
- Nimgaonkar VL, Fujiwara TM, Dutta M, Wood J, Gentry K, Maendel S, Morgan K, Eaton J (2000). Low prevalence of psychoses among the Hutterites, an isolated religious community. American Journal of Psychiatry 157(7):1065-1070. PMID: 10873912.
Vishwajit Nimgaonkar, MD, PhD, Assumes Behavioral Health Leadership Role at the VA Pittsburgh Healthcare System
Congratulations to Dr. Vishwajit Nimgaonkar, Professor of Psychiatry and Human Genetics… and now, Associate Chief of Staff for Behavioral Health at the VA Pittsburgh Healthcare System! Dr. Nimgaonkar assumes his new role today, May 13, 2019. Dr. Nimgaonkar is the director of the Program for Genetics and Psychoses, where he seeks to identify genetic and environmental factors that can increase the risk for...
Department Researchers Pioneer Method for Growing Human Neurons That Could Create Better Models of Brain Diseases and More Accurately Identify New Treatments
Pictured above: Vishwajit Nimgaonkar, MD, PhD and Leonardo D'Aiuto, PhD Unlike cells from other organs such as the liver or lungs, neurons are very difficult to collect from a living patient. In fact, one of the biggest hurdles to treating brain diseases is a lack of cells that researchers can use to study the conditions and develop new therapies. Over the last decade, a method to “reprogram” human skin cells into...
Findings by Dr. Amy Byrd and Colleagues Find the Interaction between Monoamine Oxidase A and Early Maltreatment Puts Women at Risk for Personality Pathology via Emotional Reactivity
Research consistently demonstrates that common polymorphic variation in monoamine oxidase A (MAOA) moderates the influence of childhood maltreatment on later antisocial behavior in males, with growing evidence that the “risk” allele (high vs. low activity) differs in females. These findings underscore the need for continued research regarding this gene by environment interaction (GxE) in female samples. Moreover...
Dr. Vishwajit Nimgaonkar Continues Program “Without Walls” to Improve Global Mental Health
Vishwajit Nimgaonkar, MD, PhD, Professor of Psychiatry and Human Genetics and Director, Program for Genetics and Psychosis, has dedicated the greater part of his career—spanning 25 years—to improving global mental health. Addressing the increasing global burden of mental illness and substance use disorders, he has collaborated with colleagues from Pittsburgh to Delhi, Mansoura, Cairo, and Hyderabad. Dr. Nimgaonkar...